{
    "2020-05-12": [
        [
            {
                "time": "2023-04-25",
                "original_text": "Allscripts (MDRX) Q1 Earnings and Revenues Miss Estimates",
                "features": {
                    "keywords": [
                        "Allscripts",
                        "Q1",
                        "Earnings",
                        "Revenues",
                        "Miss",
                        "Estimates"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-25",
                "original_text": "National Vision (EYE) Q1 Earnings Top Estimates, Margin Falls",
                "features": {
                    "keywords": [
                        "National",
                        "Vision",
                        "Q1",
                        "Earnings",
                        "Top",
                        "Estimates",
                        "Margin",
                        "Falls"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "retail"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-25",
                "original_text": "Integer Holdings (ITGR) Q1 Earnings & Revenues Top Estimates",
                "features": {
                    "keywords": [
                        "Integer",
                        "Holdings",
                        "Q1",
                        "Earnings",
                        "Revenues",
                        "Top",
                        "Estimates"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-25",
                "original_text": "ESG Stocks Remain Resilient to Virus Slump: 5 Top Picks",
                "features": {
                    "keywords": [
                        "ESG",
                        "Stocks",
                        "Resilient",
                        "Virus",
                        "Slump",
                        "Top",
                        "Picks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "environmental",
                        "social",
                        "governance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-25",
                "original_text": "China's Junshi Bio, Lilly to Co-Develop Covid-19 Antibody Therapies",
                "features": {
                    "keywords": [
                        "China",
                        "Junshi",
                        "Bio",
                        "Lilly",
                        "Covid-19",
                        "Antibody",
                        "Therapies"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}